Early Adjuvant Intravenous Vitamin C Treatment in Septic Shock may Resolve the Vasopressor Dependence
Journal: International Journal of Microbiology & Advanced Immunology (IJMAI) (Vol.05, No. 01)Publication Date: 2017-07-28
Authors : Nabil Habib T Ahmed I;
Page : 77-81
Keywords : Critical; Sepsis; Septic Shock; Vitamin C; Vasopressor.;
Abstract
Evidence is emerging that intravenous administration of high-doses of vitamin C may have beneficial effect and can be used
as adjuvant therapy of severe sepsis and septic shock. The aim of this study was to evaluate the role of early intravenous high doses of vitamin C as adjuvant treatment in patients with septic shock. 100 patients with septic shock were enrolled, randomized into 2 groups. Early vitamin C (EVC) group (n=50) received intravenous 1.5 gm vitamin C (ascorbic acid) every 6 hours in the first 24 hours after admission until ICU discharge plus conventional sepsis treatment. Other 50 patients were enrolled as a control. The primary outcomes were the need for organ supportive measures and length of ICU stay. There were no differences in duration on MV (p= 0.187), need for RRT (p=0.412), or ICU mortality (p=0.138). The mean number of days on vasopressor was significantly less in EVC group than in control group (2.30 Vs 6.50 days, p=0.001). There was a statistically significant difference in ICU stay between the two groups (p=0.04). Early vitamin C in septic shock may resolve the vasopressor-dependent septic shock rapidly with no benefit on mortality.
Other Latest Articles
- Efficacy of APOQUEL® for the Control of Otitis Externa Secondary to Allergic Skin Disease in Client-Owned Dogs
- Replacement of Soybean Meal with Silkworm Meal In The Diets of White Leghorn Layers and Effects on Performance, Apparent Total Tract Digestibility, Blood Profile and Egg Quality
- Effect of Enrichment of In Vitro Fertilization Medium with Cysteine on Fertilization and Embryo Development in Buffaloes
- Prevalence of Ovine Lungworm and Associated Risk Factors in and Around Debre Berhan Town, Ethiopia
- Predictors and Outcomes of No-Reflow Phenomenon Following Primary Percutaneous Intervention for ST Elevation Myocardial Infarction
Last modified: 2017-11-01 02:43:06